Alternatives to mifepristone for early medical abortion

Moreno-Ruiz, N.L.; Borgatta, L.; Yanow, S.; Kapp, N.; Wiebe, E.R.; Winikoff, B.

doi:10.1016/j.ijgo.2006.09.009

« Previous Next »International Journal of Gynecology & Obstetrics
Volume 96, Issue 3 , Pages 212-218, March 2007

Alternatives to mifepristone for early medical abortion

N.L. Moreno-Ruiz
- Department of Obstetrics and Gynecology, Boston University School of Medicine, Boston MA, USA
- Corresponding author. Department of Obstetrics and Gynecology, Boston University School of Medicine, 85 East Concord St, 6th Floor, Boston, MA 02118, USA. Tel.: +1 617 414 5112 (work), +1 617 459 5290 (home); fax: +1 617 414 7300.
L. Borgatta
- Department of Obstetrics and Gynecology, Boston University School of Medicine, Boston MA, USA
S. Yanow
- Abortion Access Project, Cambridge MA, USA
N. Kapp
- Department of Obstetrics and Gynecology, Boston University School of Medicine, Boston MA, USA
E.R. Wiebe
- Department of Family Practice, University of British Columbia, Vancouver, BC, Canada
B. Winikoff
- Gynuity Health Projects, New York, USA

Received 30 May 2006; received in revised form 17 August 2006; accepted 11 September 2006. published online 10 November 2006.

Abstract

Objective

To review published reports of first-trimester medical abortion regimens that do not include mifepristone.

Methods

Reports listed in Pubmed and Medline on prospective and controlled trials of the efficacy of misoprostol, alone or associated with methotrexate, for first-trimester abortion were analyzed if they included more than 100 participants and were published since 1990.

Results

The efficacy of regimens using misoprostol alone ranged from 84% to 96%, and when misoprostol was used with methotrexate the efficacy ranged from 70% to 97%. Efficacy rates were influenced by follow-up interval. Treatment for infection, bleeding, and incomplete abortion were infrequent with both methods (0.3%–5%).